by admin | Jan 17, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
HOUSTON, Jan. 17, 2019 /PRNewswire/ — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid...
by admin | Jan 16, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Sanford Health is a contributing partner of the 2019 World Stem Cell Summit. Philanthropist Denny Sanford received the RMF Stem Cell Action “Leadership” Award, at the 2013 World Stem Cell Summit in San Diego. It was his vision and focused philanthropy that...
by admin | Jan 16, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Who owns the brand “stem cells” ? Lofty scientific societies, such as the International Society for Stem Cell Research (ISSCR)? How about medical associations like the American Society for Plastic Surgeons (ASPS) or members of the International Federation...
by admin | Jan 15, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News
How profound is the coming age of cell and gene therapies? Answered simply, it will profoundly impact medicine and humanity. Converging “Future Shock” technologies. Societal change. How big? Think the Industrial Revolution- the Bronze Age- the discovery...
by admin | Jan 14, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Accomplish your goals at World Stem Cell Summit & Phacilitate Leaders World, Jan. 22-25, Miami! Dear Colleague, With 2,000 attendees from 40 nations, the 14th World Stem Cell Summit and award-winning Phacilitate Leaders World conferences in Miami, Florida will...
by admin | Jan 10, 2019 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Florida-based company Longeveron’s goal is to provide a biological solution for aging-related diseases, and is dedicated to developing safe cell-based therapeutics to revolutionize the aging process and improve quality of life. The company’s research focus areas...
